Vascular Dementia Clinical Trial
Official title:
A Feasibility Study on the Effects of Vestibular Training as a Fall Prevention Strategy in the Elderly
NCT number | NCT03221296 |
Other study ID # | 17-5055 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | June 27, 2017 |
Est. completion date | August 23, 2018 |
Verified date | October 2018 |
Source | University Health Network, Toronto |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A feasibility study of a vestibular rehabilitation program in a sample of cognitively impaired clinical patients to guide future trials.
Status | Completed |
Enrollment | 29 |
Est. completion date | August 23, 2018 |
Est. primary completion date | August 23, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 65 Years and older |
Eligibility |
Inclusion Criteria: - Elderly people ages 65 and older - English speaking - Can log their participation or have a caregiver log on their behalf - Mild/moderate dementia [(1) Alzheimer's disease, (2) small vessel vascular dementia not related to stroke and (3) mixed dementia of Alzheimer's or small vessel vascular not related to stroke] or mild/moderate cognitive impairment - Vestibular Impairment Exclusion Criteria: - Neurological disease (e.g. seizures, stroke, hemorrhage, central nervous system tumor, multiple sclerosis) - Being diagnosed with a psychiatric disorder (e.g. Major depression episode, post-traumatic stress disorder, generalized anxiety disorder, schizophrenia, bipolar disorder etc.) - Those with a current inner ear infection - Those with severe neck arthritis - Those with Post-Concussion Syndrome - Severe cognitive impairment as defined by a MoCA <15 - Following etiologies of dementia: Dementia due to Lewy bodies, Parkinson's disease, Huntington's Disease, Frontotemporal Dementia, Normal Pressure Hydrocephalous |
Country | Name | City | State |
---|---|---|---|
Canada | Toronto Western Hospital | Toronto | Ontario |
Lead Sponsor | Collaborator |
---|---|
University Health Network, Toronto |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of falls/near fall experiences through the Falls Video Analysis Questionnaire (FVAQ) | Measured by comparing the test score change from baseline to follow up at 3 months and again at 6 months to determine if the therapy worked | 3 months and again 6 months after baseline | |
Secondary | Change in levels of dizziness through the Dizziness Handicap Inventory (DHI) | Measured by comparing the test score change from baseline to follow up at 3 months | 3 months | |
Secondary | Change in perceived level of confidence through the Activities Specific Balance Confidence Scale (ABC) | Measured by comparing the test score change from baseline to follow up at 3 months | 3 months | |
Secondary | Change in quality of life through The Geriatric Depression Scale (GDS) | Measured by comparing the test score change from baseline to follow up at 3 months | 3 months | |
Secondary | Cognitive status through the Montreal Cognitive Assessment (MoCA) | Measured by comparing the test score change from baseline to follow up at 3 months | 3 months | |
Secondary | Change in physical functioning through the head impulse test (HIT) | Measured by comparing the test score change from baseline to follow up at 3 months | 3 months | |
Secondary | Number of patients who can successfully complete Head Impulse Test (HIT) | Shall be measured by proportion of participants completing test (did not need to stop for any reason) | 3 months | |
Secondary | Number of patients who can successfully complete Head Shake Test (HST) | Shall be measured by proportion of participants completing test (did not need to stop for any reason) | 3 months | |
Secondary | Number of patients who can successfully complete Dynamic Gait Index (DGI) | Shall be measured by proportion of participants completing test (did not need to stop for any reason) | 3 months | |
Secondary | Number of patients who can successfully complete the test of dynamic visual acuity (DVA) | Shall be measured by proportion of participants completing test (did not need to stop for any reason) | 3 months | |
Secondary | Number of patients who can successfully complete the modified clinical test of sensory interaction on balance (mCTSIB) | Shall be measured by proportion of participants completing test (did not need to stop for any reason) | 3 months | |
Secondary | Completeness of questionnaires and which questions were: skipped, missed or difficult to understand for the Dizziness Handicap Inventory (DHI) | Shall be measured by percentage of test items completed | 3 months | |
Secondary | Completeness of questionnaires and which questions were: skipped, missed or difficult to understand for the Montreal Cognitive Assessment (MoCA) | Shall be measured by percentage of test items completed | 3 months | |
Secondary | Completeness of questionnaires and which questions were: skipped, missed or difficult to understand for the Quality of Life in Alzheimer's Disease (QOL-AD) | Shall be measured by percentage of test items completed | 3 months | |
Secondary | Completeness of questionnaires and which questions were: skipped, missed or difficult to understand for the World Health Organization Quality of Life - BREF (WHOQOL-BREF) | Shall be measured by percentage of test items completed | 3 months | |
Secondary | Completeness of questionnaires and which questions were: skipped, missed or difficult to understand for the Activities Specific Balance Confidence scale (ABC) | Shall be measured by percentage of test items completed | 3 months | |
Secondary | Completeness of questionnaires and which questions were: skipped, missed or difficult to understand for the Geriatric Depression Scale (GDS) | Shall be measured by percentage of test items completed | 3 months | |
Secondary | Number of patients who successfully adhered to the vestibular rehabilitation program through the Problematic Experiences of Therapy scale (PETs) | filled out by both, or either one of, the patient or caregiver | 3 months | |
Secondary | Attrition Rate | Will be measured as the percentage of those who reached follow-up compared to those who completed baseline | 3 months | |
Secondary | Number of patients willing to participate | Determined by the proportion of patients saying yes out of those contacted | 3 months | |
Secondary | Change in quality of life through The World Health Organization Quality of Life - BREF (WHOQOL-BREF) | Measured by comparing the test score change from baseline to follow up at 3 months | 3 months | |
Secondary | Change in quality of life through The Quality of Life in Alzheimer's Disease (QOL-AD) | Measured by comparing the test score change from baseline to follow up at 3 months | 3 months | |
Secondary | Change in physical functioning through the head shake test (HST) | Measured by comparing the test score change from baseline to follow up at 3 months | 3 months | |
Secondary | Change in physical functioning through the dynamic visual acuity (DVA) | Measured by comparing the test score change from baseline to follow up at 3 months | 3 months | |
Secondary | Change in physical functioning through the modified clinical test of sensory interaction on balance (mCTSIB) | Measured by comparing the test score change from baseline to follow up at 3 months | 3 months | |
Secondary | Change in physical functioning through the dynamic gait index (DGI) | Measured by comparing the test score change from baseline to follow up at 3 months | 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04567745 -
Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers
|
Phase 1 | |
Recruiting |
NCT04109963 -
Trial of Remote Ischemic Pre-conditioning in Vascular Cognitive Impairment
|
Phase 2 | |
Recruiting |
NCT04335994 -
ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing
|
N/A | |
Not yet recruiting |
NCT06416371 -
Retinal Vessel Leakage in Cerebral Small Vessel Disease
|
||
Completed |
NCT01761227 -
Efficacy and Safety of Fufangdanshen Tablets in Mild to Moderate Vascular Dementia
|
Phase 2 | |
Active, not recruiting |
NCT01208675 -
The Swedish BioFINDER Study
|
||
Completed |
NCT00165763 -
Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia
|
Phase 4 | |
Completed |
NCT00621647 -
Seroquel- Agitation Associated With Dementia
|
Phase 3 | |
Recruiting |
NCT04095962 -
Effects of a Multicomponent Exercise Intervention on Physical and Cognitive Function of Older Adults With Dementia
|
N/A | |
Recruiting |
NCT03275363 -
The University of Hong Kong Neurocognitive Disorder Cohort
|
N/A | |
Active, not recruiting |
NCT03804229 -
Efficacy and Safety of Butylphthalide Soft Capsule for the Treatment of Vascular Dementia
|
Phase 3 | |
Enrolling by invitation |
NCT03724136 -
Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study
|
N/A | |
Completed |
NCT02453932 -
Efficacy and Safety of Tianzhi Granule in Mild to Moderate Vascular Dementia
|
Phase 3 | |
Completed |
NCT00947531 -
A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia
|
Phase 4 | |
Not yet recruiting |
NCT03702543 -
Managing Vascular Dementia Risk Factors With SymTrend
|
Phase 1 | |
Enrolling by invitation |
NCT02147652 -
Personalized Music Therapy and Agitation in Dementia
|
N/A | |
Recruiting |
NCT04114994 -
Longitudinal Cognitive Assessment by BoCA
|
||
Recruiting |
NCT06034509 -
Cognitive and Vascular Functioning Following TBI
|
||
Recruiting |
NCT05921266 -
Urolithin A Supplementation in Middle-aged Adults With Obesity
|
N/A | |
Not yet recruiting |
NCT01466543 -
Effect of Zydena (Udenafil) on Cerebral Blood Flow and Peripheral Blood Viscosity
|
Phase 2 |